2024 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec 2026 2025

Infectious Disease - MSBI Schedule, 3/1 to 3/31, 2025   (as of 4:12pm Dec 18)

23 February24 Mo25 Tu26 We27 Th28 Fr1 March
2 March3 Mo4 Tu5 We6 Th7 Fr8 Sa
9 Su10 Mo11 Tu12 We13 Th14 Fr15 Sa
16 Su17 Mo18 Tu19 We20 Th21 Fr22 Sa
23 Su24 Mo25 Tu26 We27 Th28 Fr29 Sa
30 Su31 Mo1 April2 We3 Th4 Fr5 Sa

Contact suzanne.franco@mountsinai.org if you have questions.   Schedule last updated Dec 18 16:09 2024.   2024 (23-25) Sanchg15  Jun 17 22

For antibiotic approval, 24 hours a day, contact MSBI Antibiotic Approval on EPIC secure chart

For Consults please contact the MSBI Infectious Diseases Consult group on EPIC secure chat or the fellow listed on call on AMION

Fellows long distance pager prefix 14620 + pager number.

Administration / Escalation

1 - David Perlman MD, Chief, Infectious Diseases Cell: 917-282-5804

2 - Stanley Yancovitz MD, Fellowship Program Site Director Cell: 917-655-4552

3 - MSBI Hospital Director of Nursing: 212-420-3910

4 - MSBI Hospital Administrator on Duty: 212-420-3900

Infection Prevention

On weekdays, contact the Infection Prevention Department at 212-420-2853. On evenings, nights and weekends, please call the Nursing Supervisor for any bed management/infection prevention issues.

The Nursing Supervisor can reach Infection Prevention On Call at 646-799-6024.

Infection Control Policy #009, Care of the Patient with Communicable Diseases in the Inpatient and Outpatient Setting

Candida auris**

active infection or prior history

Special Contact Precautions 

Clostridium difficile, Sapovirus, Norovirus**

active infection

Special Contact Precautions

CRE, MDR Pseudomonas, MDR Acinetobacter baumannii or any other significant MDR gram negative bacilli **

active infection or prior history within 1 year

Contact Precautions

ESBL

all sites, active infection or prior history

No precautions

MRSA**

active MRSA infection or 1 year history of MRSA in current open wound

Contact Precautions

MRSA

nasal screen (+) or prior history of nasal MRSA

No precautions

VISA/VRSA/HVISA**

active infection or prior history

Contact Precautions

VRE**

No precautions unless resistant to Linezolid and/or Daptomycin, solid organ or hematopoietic stem cell transplant within the last 12 months or NICU patient

**Patients may only be cohorted with a roommate who has the same organism (e.g. CRE+CRE; MDR Acinetobacter + MDR Acinetobacter; MRSA + MRSA)